Core Viewpoint - The stock of Tengjing Technology has experienced a significant price increase, with a cumulative rise of 30% over three consecutive trading days, leading to a classification of abnormal trading activity [1] Summary by Relevant Sections - **Stock Price Movement** - Tengjing Technology's stock price increased by 30% over the trading days of August 14, 15, and 18, 2025, indicating a substantial short-term gain [1] - **Regulatory Compliance** - The company acknowledges the abnormal trading activity as per the Shanghai Stock Exchange regulations and has conducted a self-examination [1] - **Disclosure of Information** - As of August 18, 2025, the company, its controlling shareholder, and actual controller have confirmed that there are no significant matters affecting the stock's trading volatility, nor are there any undisclosed major information [1]

Core Viewpoint - Sino Medical announced that its stock price has deviated significantly, with a cumulative increase of 200% over 30 consecutive trading days, indicating severe abnormal fluctuations in stock trading [1] Company Summary - The company's daily production and operational status is normal, with no significant changes in market environment or industry policies [1] - The company's subsidiary, Sino Shenchang, has received breakthrough medical device designation from the FDA for its self-expanding intracranial drug-coated stent system (COMETIU) and COMEX balloon microcatheter [1] - The FDA designation does not guarantee that the products will receive approval for market application in the U.S. [1] Stock Performance Summary - As of August 15, the company's stock closed at 34.57 yuan per share, with a significant cumulative increase in stock price that exceeds most of its industry peers and the Shanghai Composite Index [1] - There is a potential risk of a price decline due to the rapid increase in stock price in the short term [1]

Core Viewpoint - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (*ST Suwu) experienced a significant stock price drop exceeding 12% from August 13 to 15, 2025, indicating abnormal volatility [1] Company Situation - The company conducted a self-examination and found no significant changes in daily operations or major events [1] - The company is facing multiple risks, including the potential for forced delisting due to major legal violations [1] - The balance of non-operating funds occupied by related parties of the controlling shareholder amounts to 1,692.6071 million yuan [1] - The company's stock price has been below 1 yuan for two consecutive days, and if it remains below this threshold for 20 consecutive days, it may face termination of listing [1] - Additional challenges include contract terminations in business cooperation and the freezing of shares held by the controlling shareholder [1] - The company has issued a reminder to investors to be aware of risks and to invest rationally [1]

Core Viewpoint - The stock of Zhongke Hanwuji Technology Co., Ltd. has experienced an abnormal trading fluctuation, with a cumulative closing price increase of 30% over three consecutive trading days (August 12, 13, and 14, 2025) [1][2][3] Abnormal Trading Fluctuation - The company's stock price has deviated significantly, leading to a classification of abnormal trading according to the Shanghai Stock Exchange rules [2][3] - The company has confirmed that there are no undisclosed significant matters affecting its operations, and its business is currently normal [1][3] Company Operations and Major Events - The company is in the process of issuing A-shares to specific investors, which requires approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission [2][4] - The company has received an inquiry letter from the Shanghai Stock Exchange regarding its stock issuance application and has responded accordingly [3][5] - There have been no major changes in the market environment or industry policies that would impact the company's operations [3] Market Rumors and Misleading Information - The company has addressed recent misleading information circulating online regarding large orders, revenue forecasts, and new products, urging investors to make rational decisions [2][5] - The company has not identified any other significant events that could impact its stock price during the period of abnormal trading [3][5] Board of Directors Statement - The board of directors has confirmed that there are no undisclosed matters that should be reported according to the relevant regulations of the Shanghai Stock Exchange [3][6]

Core Viewpoint - The stock of Jishi Media experienced a continuous five-day limit-up from August 7 to August 13, 2025, with significant price fluctuations on August 8 and August 12, despite no major changes in the company's operations or performance [1] Group 1: Stock Performance - Jishi Media's stock price has significantly deviated from its fundamental performance, indicating a disconnect between market valuation and actual business conditions [1] - The company has noted that the recent stock price surge is not supported by any substantial improvement in its operational performance [1] Group 2: Investment in Film - Investors have inquired about the company's involvement in the film "731," to which Jishi Media clarified that its investment stake is minimal [1] - The expected impact of this investment on the company's financial performance is negligible, and future developments regarding this investment remain uncertain [1]

Core Viewpoint - Great Wall Military Industry (601606.SH) has experienced a significant stock price fluctuation, with a cumulative increase of over 100% in closing price deviation over a period of 10 consecutive trading days from July 31 to August 13, 2025, indicating severe abnormal trading conditions [1] Summary by Relevant Sections - **Stock Performance** The company's stock price has deviated significantly from its fundamental value, with a closing price increase exceeding 100% over the specified period [1] - **Market Regulations** According to the Shanghai Stock Exchange trading rules, this situation qualifies as a severe abnormal fluctuation in stock trading [1] - **Company Fundamentals** There has been no major change in the company's fundamentals, suggesting that the stock price increase may not be justified by underlying business performance [1] - **Investor Risks** The company warns that investors may face substantial risks if the stock price continues to rise, and it may consider applying for a trading suspension for further investigation [1]

Group 1: New Stock Issuances - China Heavy Industry (601989) has a cash option declaration period from August 13, 2025[1] - China Shipbuilding (600150) has a buyback request period from August 13 to August 15, 2025[1] - Shenkai Co. (002633) has a tender offer period from July 29 to August 27, 2025[1] Group 2: Tender Offers and Mergers - ST Kelly (300326) has a tender offer period from July 17 to August 15, 2025[1] - Fushun Special Steel (600399) has a tender offer period from August 12 to September 10, 2025[1] - China Heavy Industry (601989) is involved in an absorption merger[1] Group 3: Abnormal Fluctuations - Tianlu Convertible Bond (110060) reported severe abnormal fluctuations on July 30, 2025[2] - Henghe Precision (300539) reported abnormal fluctuations on July 29, 2025[2] - ST Suwu (600200) reported abnormal fluctuations on August 6, 2025[2]

Core Viewpoint - The company, Aowei New Materials (688585.SH), has issued a risk warning regarding its stock price, which has surged by 1,320.05% from July 9, 2025, to August 5, 2025, indicating potential volatility and risks for investors [1] Summary by Relevant Sections - Stock Price Performance - The stock price of Aowei New Materials has increased by 1,320.05% over the specified period [1] - Trading Volatility - The stock has experienced multiple instances of abnormal trading fluctuations and severe volatility during this time frame [1] - Future Implications - If the stock price continues to rise, the company may apply for a continuous trading suspension review from the Shanghai Stock Exchange, which could pose significant risks for investors participating in trading [1]

Group 1 - The core viewpoint of the article highlights that Shengtong Energy's stock has reached the daily limit increase, with a latest price of 13.99 yuan and a total market capitalization of 3.949 billion yuan, indicating significant investor interest and activity [1] - The company's stock price has experienced an abnormal fluctuation, with a cumulative closing price increase deviation exceeding 20% over the last two trading days [1] - Shengtong Energy's main business involves the procurement, sales, and transportation services of LNG, utilizing both domestic market price procurement and a five-year long-term agreement for "import LNG window one-stop" procurement [1] Group 2 - The profitability of the company's LNG business is influenced by fluctuations in domestic LNG market prices, which are affected by various factors including market supply and demand as well as international natural gas prices [1]

针对公司股票异常波动，公司对相关事项进行了核实，现就有关情况说明如下： 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、股票交易异常波动的情况介绍 胜通能源股份有限公司（以下简称"公司"或"本公司"，证券简称：胜通能源，证券代码：001331）的股 票交易价格连续2个交易日（7月30日、7月31日）收盘价格涨幅偏离值累计超过20%，根据《深圳证券 交易所交易规则》的有关规定，属于股票异常波动的情况。 二、公司关注、核实情况说明 本公司董事会确认：本公司目前没有任何根据《深圳证券交易所股票上市规则》等有关规定应予以披露 而未披露的事项或与该事项有关的筹划、商谈、意向、协议等；董事会也未获悉本公司有根据《深圳证 券交易所股票上市规则》等有关规定应予以披露而未披露的、对本公司股票及其衍生品种交易价格产生 较大影响的信息；公司前期披露的信息不存在需要更正、补充之处。 （一）公司前期披露的信息不存在需要补充、更正之处； （二）公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较大影响的未公开重大信 息； （ ...